4 Companies Trending Now (open)

Tickers Inside Dear Reader, According to our research, there are a few trending companies that have recently received buy ratings and showing a combination of positive investor sentiment, news headlines and blog buzz. With that said, we are not recommending buying these names but we are adding them to our stock watchlist. We will continue to monitor companies to see if the momentum continues. --------------------------------------------------------------- Sponsor [Move Over Lithium - 220 Pounds of Graphite In Every Battery]( constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska. [See Why Investors Are So Excited About This New Mineral Claim Discovery]( --------------------------------------------------------------- [Vir Biotechnology, VIR]( Summary: Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States. Michael Ulz analyst at Morgan Stanley reiterates coverage on [Vir Biotechnology (VIR)]( with a Hold rating and has set a price target of $ 30. [TipRanks.com]( reports that [Vir Biotechnology]( has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $57.50. In addition, TradingView issued a Buy rating for [VIR]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on VIR, please click here >>]( --------------------------------------------------------------- [Papa John's International, PZZA]( Summary: Papa John's operates and franchises pizza delivery and carryout restaurants in the U.S. and other specific international markets. Its dine-in and delivery restaurants operate under the brand name Papa John's. Its reportable segments include domestic company-owned restaurants, domestic commissaries, N. America franchising and international operations. Sara Senatore analyst at Bank of America Securities reiterates coverage on [Papa John's International (PZZA)]( with a Buy rating and has set a price target of $ 103. [TipRanks.com]( reports that [Papa John's International]( has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $96.67. In addition, TradingView issued a Strong Buy rating for [PZZA]( over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on PZZA, please click here >>]( --------------------------------------------------------------- Sponsor [Sell every Stock except ONE]( are down... But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month... [Ticker Revealed.]( --------------------------------------------------------------- [H&E Equipment Services, HEES]( Summary: H&E Equipment Services, Inc. is one of the largest integrated equipment services companies in the United States with full-service facilities throughout the Intermountain, Southwest, Gulf Coast & Southeast regions of the United States. Seth Weber analyst at Wells Fargo reiterates coverage on [H&E Equipment Services (HEES)]( with a Buy rating and has set a price target of $ 57. [TipRanks.com]( reports that [H&E Equipment Services]( has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $54.40. In addition, TradingView issued a Strong Buy rating for [HEES]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on HEES, please click here >>]( --------------------------------------------------------------- Sponsor [He's found a dozen 100x stocks. Now he's urging investors to take action this Friday.]( [Get the Full Story Here]( --------------------------------------------------------------- [Pliant Therapeutics, PLRX]( Summary: Pliant Therapeutics Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing novel therapies for the treatment of fibrosis. The company's lead product consist PLN-74809 and PLN-1474 which are in clinical stage. Pliant Therapeutics Inc. is based in SAN FRANCISCO, Calif. David Lebovitz analyst at Citigroup reiterates coverage on [Pliant Therapeutics (PLRX)]( with a Buy rating and has set a price target of $ 55. [TipRanks.com]( reports that [Pliant Therapeutics]( has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $50.75. In addition, TradingView issued a Buy rating for [PLRX]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on PLRX, please click here >>]( --------------------------------------------------------------- Sponsor [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [wallstreetanalystpress.com]( --------------------------------------------------------------- Sponsor [U.S. Government's Secret "Dirty Money" Scam]( Wall Street legend reveals the dark truth behind a new government plan to control your savings, checking, even your retirement accounts. [(See proof.)]( --------------------------------------------------------------- [To Cancel Your Free Subscription, click here.]( WallStreetAnalystPress.com Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to WallStreetAnalystPress. WallStreetAnalystPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy Unit 407 | Mt. Mourne | North Carolina | 28123 [UNSUBSCRIBE](